-+ 0.00%
-+ 0.00%
-+ 0.00%

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

PUBT·06/02/2026 12:33:23
Listen to the news
Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board
  • Achieve Life Sciences appointed Jeffrey Farrow and Reid Waldman to its board as it prepares a cytisinicline NDA resubmission.
  • Farrow is CFO and chief strategy officer at Tarsus Pharmaceuticals, supporting the commercial launch of XDEMVY for Demodex blepharitis.
  • Waldman is founder and CEO of Veradermics, a clinical-stage biopharmaceutical company developing therapeutics for pattern hair loss.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020830PRIMZONEFULLFEED9730149) on June 02, 2026, and is solely responsible for the information contained therein.